0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases: A Meta-Analysis

Michael T. Pedrini, MD; Andrew S. Levey, MD; Joseph Lau, MD; Thomas C. Chalmers*, MD; and Ping H. Wang, MD
[+] Article and Author Information

From the University of California, Irvine, California, and New England Medical Center, Boston, Massachusetts. Acknowledgments: The authors thank Dr. G.J. Beck, Dr. J. Walker, G. Viberti, and Dr. A. Ciavarella for providing data from their studies. Requests for Reprints: Ping H. Wang, MD, Department of Medicine, Medical Science I, C240, University of California, Irvine, CA 92717. Current Author Addresses: Dr. Pedrini: Department of Internal Medicine, Innsbruck General Hospital, Anichstrasse 35, A-6020 Innsbruck/Tyrol, Austria.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;124(7):627-632. doi:10.7326/0003-4819-124-7-199604010-00002
Text Size: A A A

Background: Dietary protein has long been thought to play a role in the progression of chronic renal disease, but clinical trials to date have not consistently shown that dietary protein restriction is beneficial.

Purpose: To use meta-analysis to assess the efficacy of dietary protein restriction in previously published studies of diabetic and nondiabetic renal diseases, including the recently completed Modification of Diet in Renal Disease Study.

Data Sources: The English-language medical literature published from January 1966 through December 1994 was searched for studies examining the effect of low-protein diets in humans with chronic renal disease. A total of 1413 patients in five studies of nondiabetic renal disease (mean length of follow-up, 18 to 36 months) and 108 patients in five studies of type I diabetes mellitus (mean length of follow-up, 9 to 35 months) were included.

Study Selection: Randomized, controlled studies were selected for nondiabetic renal disease; randomized, controlled studies or time-controlled studies with nonrandomized crossover design were selected for diabetic nephropathy.

Data Extraction: Data in tables, figures, or text were independently extracted by two of the authors.

Data Synthesis: The relative risk for progression of renal disease in patients receiving a low-protein diet compared with patients receiving a usual-protein diet was calculated by using a random-effects model. In five studies of nondiabetic renal disease, a low-protein diet significantly reduced the risk for renal failure or death (relative risk, 0.67 [95% CI, 0.50 to 0.89]). In five studies of insulin-dependent diabetes mellitus, a low-protein diet significantly slowed the increase in urinary albumin level or the decline in glomerular filtration rate or creatinine clearance (relative risk, 0.56 [CI, 0.40 to 0.77]). Tests for heterogeneity showed no significant differences in relative risk among studies of either diabetic or nondiabetic renal disease. No significant differences were seen between diet groups in pooled mean arterial blood pressure (diabetic and nondiabetic patients) or glycosylated hemoglobin level (diabetic patients only).

Conclusion: Dietary protein restriction effectively slows the progression of both diabetic and nondiabetic renal diseases.

*Deceased.

Figures

Grahic Jump Location
Figure 1.
Effect of dietary protein restriction on progression of nondiabetic renal diseases.

Data presented as risk ratios with 95% CIs on log scale.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Effect of dietary protein restriction on progression of diabetic renal disease.

Data presented as risk ratios with 95% CIs on log scale.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)